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Transducin was [32P]ADP-ribosylated  by  cholera 
toxin  in  bovine  retinal  rod  outer  segments  and  then 
partially  purified on w-amino octyl agarose  to remove 
other  ADP-ribosylated  proteins.  Trypsin  digestion of 
the  ADP-ribosylated  transducin  and  further  purifica- 
tion using boronate-polyacrylamide beads and high 
performance  liquid  chromatography  yielded a single 
radiolabeled  tetrapeptide,  Ser-Arg-Val-Lys.  The ADP- 
ribose is linked to the guanidinium  group of arginine. 
Cholera toxin, an exotoxin produced by Vibrio cholerae, 
activates  adenylate cyclase in many  vertebrate cells by cata- 
lyzing ADP-ribosylation of N,’ (1-3). ADP-ribosylation by 
cholera toxin inhibits the GTPase associated with N, and 
prolongs the regulatory  protein’s activated  state (4). Cholera 
toxin also ADP-ribosylates transducin, a protein of retinal 
ROS which is structurally ( 5 )  and functionally (6-8) homol- 
ogous to N,. This  covalent modification inhibits  transducin’s 
GTPase activity. Guanosine  triphosphate analogs (8-10) and 
either hormones (9) or light (8) markedly enhance cholera 
toxin-catalyzed  ADP-ribosylation of N, or transducin, respec- 
tively. Thus,  the two proteins  exhibit  remarkable  similarities 
with  respect both  to  the  functional effects df toxin-catalyzed 
ADP-ribosylation and also to the conditions under which 
ADP-ribosylation  can occur. 
Here, we report  the  primary  structure of the  site  on  trans- 
ducin that is ADP-ribosylated by cholera toxin. It is likely 
that  the  toxin  ADP-ribosylates a closely homologous site  on 
N,. 
EXPERIMENTAL  PROCEDURES 
Materials-Frozen, dark-adapted bovine retinas were obtained 
from  American Stores,  Lincoln,  NE.  Other  materials were obtained 
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The abbreviations used are: N,, stimulatory  guanine nucleotide- 
binding regulatory protein of adenylate cyclase; ROS, rod outer 
segments; T,,, a-subunit of transducin, HPLC, high performance 
liquid chromatography;  dns  or  dansyl,  5-dimethylaminonaphthalene- 
1-sulfonyl. 
commercially as follows: [LI-~*P]NAD+ (New England Nuclear), w -  
amino octyl  agarose (Miles), boronate-polyacrylamide  beads and poly- 
acrylamide gel electrophoresis materials  (Bio-Rad),  trypsin  (EC 
3.4.21.4; treated with L-1-p-tosylamino-2-phenylethyl chloromethyl 
ketone, Millipore),  chemicals for sequence analysis (Pierce), and 
dansyl chloride (Eastman). Cholera toxin  (Schwarz/Mann) was ac- 
tivated  just  prior  to use (3). 
Preparation of ADP-ribosylated T,-ROS were isolated  from 500 
retinas  in  the  dark  as described by Fung  and  Stryer  (11).  The ROS, 
which contained 150-250 mg of rhodopsin, were then  suspended in 
50 ml of 200 mM potassium  phosphate, pH 6.8, 10 mM thymidine, 5 
mM MgCI,,  0.5 mM dithiothreitol, 10 FM guanosine-5’-(/3,y-im- 
ino)triphosphate, 1 mM [32P]NAD+ (20 Ci/mol), and 50 pg/ml of 
cholera toxin. After incubating  in  the light for 3  h at  20 “C, the  ROS 
were extracted four times with  120 ml of 5 mM Tris-C1, pH 7.5, 0.5 
mM MgCI,, 100 PM GTP, 1 mM dithiothreitol, and 0.1 mM phenyl- 
methylsulfonyl  fluoride.  After the  extracts were pooled, chromatog- 
raphy on w-amino octyl  agarose was performed as previously  described 
(12). After  sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
of fraction  aliquots  on  10% gels (13), gels were dried  on tissue  paper 
and exposed Kodak XAR-5 film. Fractions containing [32P]ADP- 
centrated using Amicon PM-10 filters. The yield of [32P]ADP-ribo- 
ribosylated T, (identified by autoradiography) were pooled and  con- 
sylated T,, was 10-2.5 nmol. 
Isolation of ADP-ribosylated  Tryptic Fragrnent-[[”*P]ADP-ribosy- 
lated T, was exposed to trypsin (1:100, w/w) in 0.2 M ammonium 
acetate,  pH 8.5, 2 M urea,  and 1 mM thioglycollate for 1 h a t  37 “C. 
ADP-ribosylated peptides were isolated using boronate-polyacryl- 
amide  chromatography  as previously  described (14)  and  then  further 
purified by reverse phase HPLC (Fig. 1). In these two chromato- 
graphic steps, approximately 80% of the ”P co-purified with the 
peptide. 
in an automatic amino acid analyzer (Beckman Model 119C) (15) 
Amino Acid Sequencing-Amino acid  composition was determined 
and  the  peptide was  sequenced using a  micro dansyl-Edman procedure 
(16).  For  NH2-terminal  determination  and sequencing,  a portion of 
the  intact  peptide (0.3 nmol)  or  an  aliquot of the aqueous phase of 
each  Edman  degradation  step were dansylated (16) and hydrolyzed 
in 6 N HC1 for 6-10 h a t  110 “C. The  dns-amino  acids were identified 
on polyamide thin layer chromatography  (Schleicher & Schuell). A 
second  aliquot of the aqueous phase was hydrolyzed before dansyla- 
tion for analysis of amino acid composition using polyamide thin 
layer chromatography. 
Intact  peptide (0.3 nmol) was  also  digested with carboxypeptidases 
A and B (1:100, mol/mol) in  0.1 M NaHC03,  pH 9.0, for 2 h a t  37 “C. 
Free amino acids were dansylated  and identified as  dns-amino  acids 
using  polyamide thin layer chromatography. 
The  mass of the  ADP-ribosylated  peptide was determined by liquid 
secondary  ion mass  spectrometry  (17) at  the Bio-organic  Biomedical 
Mass Spectrometry Resource of the University of California, San 
Francisco. 
ADP-ribosyl arginine was synthesized (18) and  then purified  using 
horonate-polyacrylamide beads  (14) or high  voltage paper electropho- 
resis as described in Fig. 1. The purified ADP-ribosyl arginine was 
reacted with Edman reagent under the same conditions that were 
used for the  ADP-ribosylated  peptide  and  detected  after high voltage 
paper electrophoresis  using ultraviolet fluorescence or a  silver nitrate- 
ammonia  reagent  (19). 
RESULTS 
The ADP-ribosylated peptide isolated by reverse phase 
HPLC was homogeneous by high voltage paper electropho- 
resis. The homogeneity of this  peptide was further confirmed 
by NHa-terminal analysis which showed serine as the sole 
NH,-terminal  amino acid. The yield of the  final  product was 
8.28 nmol by amino acid analysis  and 7.73 nmol by measure- 
ment of 32P radioactivity, demonstrating  the presence of one 
ADP-ribosyl  moiety/peptide molecule. 
The  amino acid  sequence was established  as  Ser-Arg-Val- 
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FIG. 1. Reverse  phase HPLC of [32P]ADP-ribosylated  tryp- 
tic  peptide. The boronate-polyacrylamide  eluate was lyophilized and 
dissolved in 500 pl of 50 mM pyridine, 25 mM acetic acid (pH 5 .5 ) .  
The material was fractionated by HPLC on a Cl8 reverse phase 
column  (Alltech, VYDAC 201-TP, 10 pm; 4.6 X 250 mm) by isocratic 
elution with 50 mM pyridine, 25 mM acetic  acid  (pH 5.5). Flow rate 
was 0.5 ml/min. The column  effluent (0.5 ml/fraction)  was  monitored 
for '"P using  scintillation  counting of Cerenkov  radiation. The inset 
shows  the  electrophoretic  and  autoradiographic  analysis of the ['"PI 
ADP-rihosylated tryptic peptide before ( A )  and after ( R )  reverse 
phase  HPLC. High  voltage paper  electrophoresis was  performed on 
Whatman 3MM paper in pH 2.1 buffer (HCOOH:CH:,COOH:H20, 
218:63:2219 by volume) a t  2kV for 30 min. Subsequent autoradiog- 
raphy was carried  out  on Kodak XAR-5 film. 
Lys by a  micro dansyl-Edman procedure (15) in  which  each 
newly exposed NH2-terminal was determined following dan- 
sylation. This sequence was confirmed using a subtractive 
method by determining the amino acid composition of the 
residual peptide after each Edman cycle. Digestion of the 
intact  peptide  with  carboxypeptidases A and B released  lysine 
and  valine,  confirming  the  COOH-terminal sequence. How- 
ever, determination of the amino acid composition by acid 
hydrolysis  revealed the following five amino acids: Ser 0.85, 
Gly 0.45, Val 1.10, Lys 0.91, and Arg 1.13. The  presence of 
glycine in acid hydrolysates of peptides  that  contain  ADP- 
ribose has been  previously reported  (20);  it  appears to result 
from degradation of adenine during acid treatment. Mass 
spectrometry of the  ADP-ribosylated  peptide revealed a  mass 
of 1030 Da, which corresponds  to  the  mass  predicted  from  the 
sequence data. 
To determine which amino acid is ADP-ribosylated by 
cholera toxin,  aliquots of the residual water  phase ( 1 3 ,  after 
each of the  sequential  Edman  reaction cycles, were subjected 
to high voltage paper electrophoresis and autoradiography 
(Fig.  2). Following the  first  Edman  reaction cycle, the  water 
phase  contained  three radiolabeled  species  with  a net positive 
+ 
FIG. 2. Electrophoretic and autoradiographic analysis of 
Edman-degraded materials. After each cycle of the sequential 
Edman  degradation,  aliquots (3  gl) of the  aqueous  phase (30 111) were 
subjected to high voltage paper  electrophoresis  and  autoradiography, 
as described in Fig. 1. Numbers at the  origin indicate  the  number of 
Edman degradation cycles: 0, untreated, ADP-ribosylated peptide 
after lyophilization; 1, ADP-ribosylated  peptide following removal of 
the NH,-terminal serine; 2 and 3, sequential treatments of ADP- 
ribosylated peptide  to remove  successive NH,-terminal  amino acids. 
charge at   pH 2.1. Although we have not defined the chemical 
structures of the three species,? their conversion to a uni- 
formly migrating species during the next Edman reaction 
cycle suggests that the ADP-ribose is linked to the second 
amino acid,  arginine. This was confirmed by the finding that 
the  electrophoretic mobility of the  Edman  derivative of au- 
thentic ADP-ribosyl arginine was identical to that of the 
major '"P-labeled species observed after  the second Edman 
reaction cycle. The  resistance of the  arginine-valine bond  in 
the ADP-ribosylated peptide to tryptic hydrolysis also sug- 
gests that arginine's guanidinium group was modified. Fur- 
thermore,  attachment of the  ADP-ribose  to  one of the  other 
amino acids is unlikely since  the  c-amino group of lysine can 
be dansylated in the intact peptide (result not shown) and 
valine has no reactive side group. We propose that for two 
reasons serine is also not the acceptor for the ADP-ribose. 
The radiolabeled product of the  first  Edman  degradation cycle 
is altered in the  next cycle and  the  ADP-ribosylated  Edman 
derivative of serine  should  not have  a net positive  charge at  
pH 2.1. All the evidence thus  indicates  that  an  arginine  on 
transducin  is  the  acceptor for cholera  toxin-transferred  ADP- 
ribose. 
We suspect  that  the  electrophoretic heterogeneity of the radiola- 
beled species after  the  first  Edman  degradation cycle is  partly  due  to 
incomplete reaction of the c-amino group on lysine with Edman 
reagent. In addition, lyophilization alone (before the first Edman 
cycle) introduced  small  amounts of slower migrating '"P-labeled ma- 
terial (Fig. 2, lane 0). The first Edman degradation cycle, which 
included  four  lyophilization steps (16). markedly  increased the 
amounts of these slower migrating species. Appearance of a  homo- 
geneously migrating species after the next cycle suggests that the 
altered mobility  was due  to  changes in amino acid residues distal  to 
the second amino acid, arginine. Such changes could have resulted 
from radiation  damage or from pH  changes  during lyophilization. 
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DISCUSSION 3. Johnson. G. L.. Kaslow. H. R.. and Bourne. H. R. (1978) J.  Biol. 
This  is  the  first  identification of an  ADP-ribosylated argi- 
nine in a protein that is specifically ADP-ribosylated by 
cholera toxin.  Incubations of cholera toxin with NAD' and 
various  amino  acids previously  showed that  the  guanidinium 
group of arginine can serve as an acceptor for ADP-ribose 
(21). Like cholera toxin, two other bacterial toxins affect 
cellular metabolism by mono-ADP-ribosylating specific cel- 
lular proteins (22, 23). Diphtheria  toxin  ADP-ribosylates  di- 
phthamide on elongation factor 2 (24) and pertussis toxin 
ADP-ribosylates  an  asparagine  on  retinal t ran~ducin.~  In   ad-  
dition,  ADP-ribosylation of an  arginine  on  RNA polymerase 
has been reported  during T4 phage infection of Escherichia 
coli (20). Thus,  each  toxin  appears  to  ADP-ribosylate a unique 
amino acid on  its specific protein  substrate. 
Because of the close structural  and  functional  similarities 
between N, and  transducin, we predict  that  the  amino acid 
sequence around  the cholera toxin  substrate  site  on N, will 
closely resemble that of transducin,  and  that  the  ADP-ribo- 
sylated  amino acid will be arginine. 
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